Indian stock exchange

Softchoice Corporation Announces $150 Million Bought Deal Offering

Monday, September 27, 2021 - 9:50pm

TORONTO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Softchoice Corporation (“Softchoice” or the “Company”) (TSX: SFTC), is pleased to announce today that the Company, along with certain funds managed by Birch Hill Equity Partners (the “Birch Hill Selling Shareholders”), Keika Limited (the “Keika Selling Shareholder”) and certain of the Company's employees and directors (the “Individual Selling Shareholders”, and, together with the Birch Hill Selling Shareholders and the Keika Selling Shareholder, the “Selling Shareholders”), have entered into an agreement with a syndicate of underwriters led by TD Securities Inc. and Goldman Sachs Canada Inc., pursuant to which the underwriters have agreed to purchase, in aggregate, 5,085,000 common shares of the Company (the “Common Shares”) at a price of $29.50 per Share (the “Issue Price”) and offer them to the public for total gross proceeds of approximately $150 million (the “Offering”).

Key Points: 
  • Under the agreement, 360,423 Common Shares will be issued from treasury by Softchoice for gross proceeds of approximately $11 million (the Treasury Offering) and an aggregate of 4,724,577 Common Shares will be sold by the Selling Shareholders for aggregate gross proceeds to the Selling Shareholders of approximately $139 million (the Secondary Offering).
  • The Company will not receive any proceeds from the sale of Common Shares associated with the Secondary Offering.
  • If the Option is exercised in full, the aggregate gross proceeds of the Treasury Offering and Secondary Offering will be approximately $11 million and $162 million, respectively.
  • Accordingly, readers should not place undue reliance on forward-looking information, which speaks only as at the date made

Cenovus and Headwater announce bought deal secondary offering of Headwater common shares worth approximately $114 million

Monday, September 27, 2021 - 8:24pm

CALGARY, Alberta, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) (“Cenovus” or the “Selling Shareholder”) and Headwater Exploration Inc. (TSX: HWX) (“Headwater” or the “Company”) announced today that they have entered into an agreement with Peters & Co. Limited and BMO Capital Markets (the “Lead Underwriters”), on behalf of a syndicate of underwriters (together with the Lead Underwriters, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, from Cenovus, through its wholly owned subsidiary, Cenovus Marten Hills Partnership (the “Partnership”), 25,000,000 common shares of the Company (the “Common Shares”) at a price of $4.55 per Common Share (the “Offering Price”) for total gross proceeds to the Selling Shareholder of $113,750,000 (the “Offering”). The Selling Shareholder has granted the Underwriters an option to purchase an additional 15% of the Common Shares issued under the Offering (3,750,000 Common Shares) at the Offering Price exercisable to cover over-allotments and for market stabilization purposes in whole or in part at any time until 30 days after the closing. The Company will not receive any of the proceeds from the Offering or the over-allotment option, if exercised.

Key Points: 
  • Cenovus currently holds, indirectly through the Partnership, 50,000,000 Common Shares, representing approximately 24.7% of the issued and outstanding Common Shares and 15,000,000 purchase warrants exercisable at $2.00 per Common Share until December 2, 2023.
  • Following the closing of the Offering, Cenovus will indirectly hold 25,000,000 Common Shares (21,250,000 Common Shares assuming full exercise of the over-allotment option), representing approximately 12.3% of the issued and outstanding Common Shares (10.5% assuming full exercise of the over-allotment option) and 15,000,000 warrants to purchase Common Shares.
  • Assuming exercise of the warrants held by Cenovus, following closing of the Offering, Cenovus would indirectly hold 40,000,000 Common Shares (36,250,000 Common Shares assuming full exercise of the over-allotment option), representing approximately 18.4% of the issued and outstanding Common Shares (16.7% assuming full exercise of the over-allotment option).
  • Cenovus is selling the Common Shares as part of its plan to reduce net debt levels towards its $10 billion interim target and accelerate shareholder returns.

Nabati Foods Files Final Prospectus and Receives CSE Conditional Approval

Monday, September 27, 2021 - 4:00pm

Nabati is also pleased to announce that it has received conditional approval to list its common shares (the Common Shares) on the Canadian Securities Exchange (CSE).

Key Points: 
  • Nabati is also pleased to announce that it has received conditional approval to list its common shares (the Common Shares) on the Canadian Securities Exchange (CSE).
  • A copy of the Final Prospectus can be found on the Companys SEDAR profile at www.sedar.com .
  • Nabati expects to complete its listing and to have the Common Shares commence trading on the CSE under the symbol MEAL, subject to the Company fulfilling all CSE listing requirements.
  • Nabati, through its wholly-owned subsidiary, Nabati Foods Inc., is a food technology company offering whole, natural, plant-based, gluten and soy-free foods for health-conscious consumers.

GABY Inc. Joins The Stock Day Podcast to Discuss their Strategy to Consolidate Cannabis Dispensaries

Monday, September 27, 2021 - 2:00pm

It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market.

Key Points: 
  • It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market.
  • Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets.
  • The Stock Day Podcast is the number one radio show of its kind in America.
  • Each of Mankind and Wild West Industries, are subsidiaries of GABY and hold a cannabis license in the State of California.

Greenbrook TMS Completes US$13.2 Million Bought Deal Public Offering

Monday, September 27, 2021 - 1:47pm

Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (Greenbrook or the Company), a leading provider of Transcranial Magnetic Stimulation (TMS) therapy in the United States, is pleased to announce the closing of its previously-announced public offering (the Offering).

Key Points: 
  • Greenbrook TMS Inc. (TSX: GTMS) (NASDAQ: GBNH) (Greenbrook or the Company), a leading provider of Transcranial Magnetic Stimulation (TMS) therapy in the United States, is pleased to announce the closing of its previously-announced public offering (the Offering).
  • The Company intends to use the net proceeds from the Offering to fund its previously-announced acquisition of Achieve TMS East, LLC and Achieve TMS Central, LLC and for working capital and general corporate purposes.
  • Clarus Securities Inc. and Desjardins Securities Inc. served as independent financial advisors to the Company in connection with the Offering.
  • Greenbrook has provided more than 675,000 TMS treatments to over 19,000 patients struggling with depression.

The Green Organic Dutchman Provides Update on Valleyfield Transition

Monday, September 27, 2021 - 1:00pm

About The Green Organic Dutchman Holdings Ltd.

Key Points: 
  • About The Green Organic Dutchman Holdings Ltd.
  • The Green Organic Dutchman Holdings Ltd. (CSE: TGOD ) (USOTC: TGODF) is a premium certified organically grown cannabis company focused on the health and wellness market.
  • For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca .
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/the-green-organic-dutchman-prov...
    SOURCE The Green Organic Dutchman Holdings Ltd.

Harvest One Announces Warrants Issued for Consulting Services

Monday, September 27, 2021 - 12:45pm

Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned cannabis-infused and non-infused consumer packaged goods ("CPG") leader, announces that further to the press release of the Company dated July 26, 2021, relating to the strategic advisory and consulting services to the Company (the "Consulting Services") to be provided by an arm's length service provider, Jonathan Carroll (the "Consultant"), the Company has issued 300,000 warrants (the "Warrants") to the Consultant pursuant to the terms of the consulting agreement entered into relating to the Consulting Services (the "Consulting Agreement").

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Harvest One Cannabis Inc. (TSXV: HVT) (OTCQB: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned cannabis-infused and non-infused consumer packaged goods ("CPG") leader, announces that further to the press release of the Company dated July 26, 2021, relating to the strategic advisory and consulting services to the Company (the "Consulting Services") to be provided by an arm's length service provider, Jonathan Carroll (the "Consultant"), the Company has issued 300,000 warrants (the "Warrants") to the Consultant pursuant to the terms of the consulting agreement entered into relating to the Consulting Services (the "Consulting Agreement").
  • Based on the terms of the Consulting Agreement, the exercise price of each Warrant is $0.089.
  • The Warrants and the Common Shares issuable on exercise of the Warrants are subject to a hold period until January 25, 2022, in accordance with applicable securities laws.
  • Harvest One is a uniquely positioned company in the cannabis space which is commercializing both cannabis-infused and non-infused products.

Freehold Royalties Ltd. Announces Closing of U.S. Royalty Assets and Credit Facility Expansion

Friday, September 24, 2021 - 5:34pm

CALGARY, Alberta, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that it has closed its previously announced transaction to acquire a high-quality U.S. royalty asset located in the Eagle Ford oil basin in Texas (the Acquired Assets) for US$180 million before closing adjustments (CAD $227 million) (the U.S. Royalty Transaction). The Acquired Assets are expected to significantly enhance the quality of Freehold’s North American royalty portfolio, improving both the near-term and long-term sustainability of Freehold’s dividend while providing further option value to return capital to our shareholders through multiple years of free cash flow growth. The U.S. Royalty Transaction further advances Freehold’s strategy of being positioned in the highest quality development areas across North America, delivering growth and low risk attractive returns to our shareholders.

Key Points: 
  • CALGARY, Alberta, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX:FRU) announces that it has closed its previously announced transaction to acquire a high-quality U.S. royalty asset located in the Eagle Ford oil basin in Texas (the Acquired Assets) for US$180 million before closing adjustments (CAD $227 million) (the U.S. Royalty Transaction).
  • In addition, as a result of and on closing of the U.S. Royalty Transaction and in accordance with the terms of the Subscription Receipts, each Subscription Receipt was exchanged for one common share of Freehold.
  • Concurrently with the closing of the U.S. Royalty Transaction, Freehold amended its credit facility agreement with a syndicate of four Canadian banks increasing the committed revolving facility to $285 million and maintaining the operating facility at $15 million.
  • The amended credit facility agreement includes a permitted increase in the committed revolving facility of up to $360 million.

Highland Income Fund (HFRO) Announces Supplement to Proxy Statement, Adjourns Special Meeting of Shareholders to Allow Review of Supplemented Proxy

Friday, September 24, 2021 - 2:47pm

The Special Meeting will reconvene on October 15, 2021 at 1:30 p.m. CDT at 300 Crescent Court, Suite 700, Dallas, Texas 75201.

Key Points: 
  • The Special Meeting will reconvene on October 15, 2021 at 1:30 p.m. CDT at 300 Crescent Court, Suite 700, Dallas, Texas 75201.
  • Terms used, but not otherwise defined herein, have the meanings assigned to them in the Proxy Statement.
  • The Highland Income Fund (NYSE:HFRO) is a closed-end fund managed by Highland Capital Management Fund Advisors, L.P. For more information visit www.highlandfunds.com/income-fund/
    About Highland Capital Management Fund Advisors, L.P.
    Highland Capital Management Fund Advisors, L.P. is an SEC-registered investment adviser.
  • Investors should consider the investment objectives, risks, charges and expenses of the Highland Income Fund carefully before investing.

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

Friday, September 24, 2021 - 1:00pm

TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross proceeds of CAD$10 million (the “Private Placement”). Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant. Each Warrant will entitle the holder to purchase one Common Share at an exercise price of CAD$0.80 per Common Share and will be immediately exercisable upon issuance for a period of five years following the issuance date.

Key Points: 
  • NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
    TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the Company or PharmaTher) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (Common Shares) and warrants to purchase common shares (Warrants) for gross proceeds of CAD$10 million (the Private Placement).
  • Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant.
  • H.C. Wainwright & Co. is acting as the exclusive placement agent for the Private Placement.
  • No securities were offered or sold to Canadian residents in connection with the Private Placement.